A Belgian court dismissed a lawsuit against EU chief Ursula von der Leyen centered on text messages she exchanged with Pfizer ...

Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...

Eleos Health, which makes software that generates clinical notes from the audio of behavioral health appointments, has raised ...

As the former president of the Navajo Nation, I support changes to make the federal dietary guidelines emphasize plant-based ...

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

WASHINGTON — President Trump began his second term Monday with a sweeping order aimed at reversing dozens of former President ...

The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...

The interim director of the World Health Organization’s Department of Epidemic and Pandemic Threat Management responds to a ...

By exiting the WHO and pulling funding, the U.S. would lose any leverage to enact those reforms,” writes Ashish K. Jha.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

President Trump rescinded an executive order that prompted the creation of three Medicare drug-pricing experiments ...

Germany’s ITM, a stalwart in the highly specialized field of radiopharmaceuticals, will soon announce the results from its ...